Letter concerning possible reactivation of Kaposi sarcoma in Rituximab treated patients
Reply to the letter by Law et al. Is Rituximab therapy in Castleman's disease a risk factor for Kaposi sarcoma reactivation?
GUERRASIO, Angelo
2010-01-01
Abstract
Letter concerning possible reactivation of Kaposi sarcoma in Rituximab treated patients
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
